Avantor Stock Forecast, Price & News

Avantor's stock was trading at $12.92 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AVTR stock has increased by 73.0% and is now trading at $22.35.
View which stocks have been most impacted by COVID-19.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Avantor.

Avantor is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Avantor.

Avantor Inc (NYSE:AVTR) announced its quarterly earnings data on Wednesday, July, 29th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.14 by $0.05. The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.49 billion. The business's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.14 earnings per share.
View Avantor's earnings history.

Avantor updated its second quarter 2020 Pre-Market earnings guidance on Tuesday, July, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.48-1.49 billion, compared to the consensus revenue estimate of $1.44 billion.

15 Wall Street analysts have issued 1-year price targets for Avantor's stock. Their forecasts range from $15.00 to $29.00. On average, they anticipate Avantor's share price to reach $21.46 in the next twelve months. This suggests that the stock has a possible downside of 4.0%.
View analysts' price targets for Avantor.

Some companies that are related to Avantor include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Waters (WAT), Bruker (BRKR), Berkeley Lights (BLI), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Quanterix (QTRX), Accelerate Diagnostics (AXDX) and Fluidigm (FLDM).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Honeywell International (HON), Johnson & Johnson (JNJ), Procter & Gamble (PG), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE), QUALCOMM (QCOM), Raytheon Technologies (RTX) and Cisco Systems (CSCO).

(AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor's stock is owned by a number of retail and institutional investors. Top institutional investors include Goldman Sachs Group Inc. (11.00%), Vanguard Group Inc. (6.29%), Nuveen Asset Management LLC (3.27%), Viking Global Investors LP (0.95%), Eminence Capital LP (0.84%) and Marshall Wace North America L.P. (0.60%). Company insiders that own Avantor stock include Devashish Ohri, Gerard Brophy, Jo Natauri, Justin Miller, Michael Wondrasch and New Mountain Investments Iii,.
View institutional ownership trends for Avantor.

AVTR stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Viking Global Investors LP, Marshall Wace North America L.P., Artal Group S.A., FMR LLC, Eminence Capital LP, Three Peaks Capital Management LLC, and Point72 Asset Management L.P.. Company insiders that have sold Avantor company stock in the last year include Devashish Ohri, Gerard Brophy, Jo Natauri, Justin Miller, Michael Wondrasch, and New Mountain Investments Iii,.
View insider buying and selling activity for Avantor.

AVTR stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Alyeska Investment Group L.P., Swiss National Bank, Sumitomo Mitsui Trust Holdings Inc., Avidity Partners Management LP, Nuveen Asset Management LLC, Bank of New York Mellon Corp, and Teachers Retirement System of The State of Kentucky.
View insider buying and selling activity for Avantor.

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVTR stock can currently be purchased for approximately $22.35.

Avantor has a market capitalization of $12.89 billion and generates $6.04 billion in revenue each year. Avantor employs 12,000 workers across the globe.

The official website for Avantor is www.avantorsciences.com.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company can be reached via phone at 610-386-1700 or via email at [email protected]